vs
安朗杰（ALLE）与礼蓝动物保健（ELAN）财务数据对比。点击上方公司名可切换其他公司
礼蓝动物保健的季度营收约是安朗杰的1.1倍（$1.1B vs $1.0B），安朗杰净利率更高（13.4% vs -24.1%，领先37.5%），礼蓝动物保健同比增速更快（12.2% vs 9.7%），过去两年安朗杰的营收复合增速更高（3.5% vs -2.6%）
安朗杰是全球知名的安防产品及解决方案供应商，面向全球生产销售机械与电子类安防产品，包括闭门器、出入口控制设备、锁具、电子门禁系统、考勤与人员效能管理系统、门体系统及相关配件，服务商业、公共机构、住宅等多领域终端用户
礼蓝动物保健是一家美国动物保健制药企业，专注于生产宠物及家畜用药品与疫苗。该公司原为礼来公司旗下子公司，2019年完成分拆独立，目前是全球第三大动物保健企业。
ALLE vs ELAN — 直观对比
营收规模更大
ELAN
是对方的1.1倍
$1.0B
营收增速更快
ELAN
高出2.4%
9.7%
净利率更高
ALLE
高出37.5%
-24.1%
两年增速更快
ALLE
近两年复合增速
-2.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $1.1B |
| 净利润 | $138.1M | $-276.0M |
| 毛利率 | 44.0% | 51.5% |
| 营业利润率 | 18.9% | -22.6% |
| 净利率 | 13.4% | -24.1% |
| 营收同比 | 9.7% | 12.2% |
| 净利润同比 | -6.8% | -3350.0% |
| 每股收益（稀释后） | — | $-0.55 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLEELAN
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $1.1B | ||
| Q3 25 | $1.1B | $1.1B | ||
| Q2 25 | $1.0B | $1.2B | ||
| Q1 25 | $941.9M | $1.2B | ||
| Q4 24 | $945.6M | $1.0B | ||
| Q3 24 | $967.1M | $1.0B | ||
| Q2 24 | $965.6M | $1.2B |
净利润ALLEELAN
| Q1 26 | $138.1M | — | ||
| Q4 25 | $147.5M | $-276.0M | ||
| Q3 25 | $188.4M | $-34.0M | ||
| Q2 25 | $159.7M | $11.0M | ||
| Q1 25 | $148.2M | $67.0M | ||
| Q4 24 | $144.1M | $-8.0M | ||
| Q3 24 | $174.2M | $364.0M | ||
| Q2 24 | $155.4M | $-50.0M |
毛利率ALLEELAN
| Q1 26 | 44.0% | — | ||
| Q4 25 | 44.5% | 51.5% | ||
| Q3 25 | 45.8% | 53.4% | ||
| Q2 25 | 45.6% | 57.5% | ||
| Q1 25 | 44.9% | 57.3% | ||
| Q4 24 | 44.1% | 50.9% | ||
| Q3 24 | 44.7% | 52.2% | ||
| Q2 24 | 44.4% | 58.2% |
营业利润率ALLEELAN
| Q1 26 | 18.9% | — | ||
| Q4 25 | 20.3% | -22.6% | ||
| Q3 25 | 21.8% | -4.4% | ||
| Q2 25 | 21.5% | 2.0% | ||
| Q1 25 | 20.9% | 5.0% | ||
| Q4 24 | 19.5% | -5.0% | ||
| Q3 24 | 22.2% | 54.3% | ||
| Q2 24 | 21.6% | -2.7% |
净利率ALLEELAN
| Q1 26 | 13.4% | — | ||
| Q4 25 | 14.3% | -24.1% | ||
| Q3 25 | 17.6% | -3.0% | ||
| Q2 25 | 15.6% | 0.9% | ||
| Q1 25 | 15.7% | 5.6% | ||
| Q4 24 | 15.2% | -0.8% | ||
| Q3 24 | 18.0% | 35.3% | ||
| Q2 24 | 16.1% | -4.2% |
每股收益（稀释后）ALLEELAN
| Q1 26 | — | — | ||
| Q4 25 | $1.70 | $-0.55 | ||
| Q3 25 | $2.18 | $-0.07 | ||
| Q2 25 | $1.85 | $0.02 | ||
| Q1 25 | $1.71 | $0.13 | ||
| Q4 24 | $1.65 | $-0.01 | ||
| Q3 24 | $1.99 | $0.73 | ||
| Q2 24 | $1.77 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $308.9M | $545.0M |
| 总债务越低越好 | $2.0B | $3.9B |
| 股东权益账面价值 | $2.1B | $6.5B |
| 总资产 | $5.3B | $13.4B |
| 负债/权益比越低杠杆越低 | 0.97× | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资ALLEELAN
| Q1 26 | $308.9M | — | ||
| Q4 25 | $356.2M | $545.0M | ||
| Q3 25 | $302.7M | $505.0M | ||
| Q2 25 | $656.8M | $539.0M | ||
| Q1 25 | $494.5M | $487.0M | ||
| Q4 24 | $503.8M | $468.0M | ||
| Q3 24 | $878.9M | $490.0M | ||
| Q2 24 | $747.5M | $416.0M |
总债务ALLEELAN
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $3.9B | ||
| Q3 25 | $2.1B | $4.0B | ||
| Q2 25 | $2.1B | $4.1B | ||
| Q1 25 | $2.0B | $4.4B | ||
| Q4 24 | $2.0B | $4.3B | ||
| Q3 24 | $2.4B | $4.4B | ||
| Q2 24 | $2.4B | $5.7B |
股东权益ALLEELAN
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.1B | $6.5B | ||
| Q3 25 | $1.9B | $6.7B | ||
| Q2 25 | $1.8B | $6.8B | ||
| Q1 25 | $1.6B | $6.4B | ||
| Q4 24 | $1.5B | $6.1B | ||
| Q3 24 | $1.6B | $6.5B | ||
| Q2 24 | $1.4B | $5.9B |
总资产ALLEELAN
| Q1 26 | $5.3B | — | ||
| Q4 25 | $5.2B | $13.4B | ||
| Q3 25 | $5.2B | $13.6B | ||
| Q2 25 | $4.9B | $13.7B | ||
| Q1 25 | $4.6B | $12.9B | ||
| Q4 24 | $4.5B | $12.6B | ||
| Q3 24 | $5.0B | $13.3B | ||
| Q2 24 | $4.8B | $13.8B |
负债/权益比ALLEELAN
| Q1 26 | 0.97× | — | ||
| Q4 25 | 0.96× | 0.60× | ||
| Q3 25 | 1.07× | 0.59× | ||
| Q2 25 | 1.16× | 0.61× | ||
| Q1 25 | 1.24× | 0.69× | ||
| Q4 24 | 1.33× | 0.70× | ||
| Q3 24 | 1.53× | 0.67× | ||
| Q2 24 | 1.69× | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $101.3M | $108.0M |
| 自由现金流经营现金流 - 资本支出 | — | $46.0M |
| 自由现金流率自由现金流/营收 | — | 4.0% |
| 资本支出强度资本支出/营收 | 2.0% | 5.4% |
| 现金转化率经营现金流/净利润 | 0.73× | — |
| 过去12个月自由现金流最近4个季度 | — | $284.0M |
8季度趋势，按日历期对齐
经营现金流ALLEELAN
| Q1 26 | $101.3M | — | ||
| Q4 25 | $240.1M | $108.0M | ||
| Q3 25 | $229.5M | $219.0M | ||
| Q2 25 | $209.7M | $237.0M | ||
| Q1 25 | $104.5M | $-4.0M | ||
| Q4 24 | $219.0M | $177.0M | ||
| Q3 24 | $231.9M | $162.0M | ||
| Q2 24 | $173.0M | $200.0M |
自由现金流ALLEELAN
| Q1 26 | — | — | ||
| Q4 25 | $200.5M | $46.0M | ||
| Q3 25 | $209.8M | $127.0M | ||
| Q2 25 | $192.0M | $180.0M | ||
| Q1 25 | $83.4M | $-69.0M | ||
| Q4 24 | $194.9M | $130.0M | ||
| Q3 24 | $212.0M | $120.0M | ||
| Q2 24 | $152.1M | $166.0M |
自由现金流率ALLEELAN
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | 4.0% | ||
| Q3 25 | 19.6% | 11.2% | ||
| Q2 25 | 18.8% | 14.5% | ||
| Q1 25 | 8.9% | -5.8% | ||
| Q4 24 | 20.6% | 12.7% | ||
| Q3 24 | 21.9% | 11.7% | ||
| Q2 24 | 15.8% | 14.0% |
资本支出强度ALLEELAN
| Q1 26 | 2.0% | — | ||
| Q4 25 | 3.8% | 5.4% | ||
| Q3 25 | 1.8% | 8.1% | ||
| Q2 25 | 1.7% | 4.6% | ||
| Q1 25 | 2.2% | 5.4% | ||
| Q4 24 | 2.5% | 4.6% | ||
| Q3 24 | 2.1% | 4.1% | ||
| Q2 24 | 2.2% | 2.9% |
现金转化率ALLEELAN
| Q1 26 | 0.73× | — | ||
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.22× | — | ||
| Q2 25 | 1.31× | 21.55× | ||
| Q1 25 | 0.71× | -0.06× | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.33× | 0.45× | ||
| Q2 24 | 1.11× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLE
| Allegion Americas | $809.9M | 78% |
| Allegion International | $223.7M | 22% |
ELAN
| Pet Health | $489.0M | 43% |
| Cattle | $296.0M | 26% |
| Poultry | $237.0M | 21% |
| Swine | $107.0M | 9% |
| Contract Manufacturing | $15.0M | 1% |
